Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1147877

registered interest
date	02/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Care Homes: Abuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the 67,500 allegations of mistreatment in care homes received by the Care Quality Commission in 2018, what steps the Government will take to increase prosecution rates.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	293437
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department expects those providing the service, local authorities and the Care Quality Commission (CQC) to take swift action where anyone alleges poor care, neglect or abuse.</p><p>Since 2015, the CQC has had prosecution powers pursuant to the Health and Social Care Act 2008. These include the criminal offence in respect of Regulation 12 (safe care and treatment) of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 in cases involving avoidable harm or a significant risk of avoidable harm to service users.</p><p>Although there were 67,500 allegations of mistreatment in care homes in 2018, the number of qualified allegations will be less than this figure. Within those qualified allegations, not all of them will be of as significant concern as to begin legal proceedings in the form of criminal prosecution. As such, numbers of prosecutions will be expected to be far lower than any number of allegations.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 08/10/2019 10:54:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	298 label Biography information for Steve McCabe

1147926

registered interest
date	02/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Healthy Start Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the uptake of Healthy Start vouchers.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	293444
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 08/10/2019 15:24:27 answering member 4380 label Biography information for Jo Churchill
tabling member	298 label Biography information for Steve McCabe

1147996

registered interest
date	02/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Department has taken to ensure that women who are unable to use alternative forms of HRT have access to HRT patches.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	293445
answer	answer is ministerial correction date of answer 07/10/2019 answer text <p>The Department fully understands that maintaining access to hormone replacement therapy (HRT) medications is vitally important to many people in this country.</p><p>We are aware of ongoing supply issues with some HRT transdermal patches due to manufacturing issues. We have been working closely with all suppliers of HRT transdermal patches to maintain overall supply to patients. Although some HRT transdermal patches are affected by supply issues, supplies of other alternative HRT transdermal patches have remained available.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 07/10/2019 16:53:50 answering member 4380 label Biography information for Jo Churchill
tabling member	298 label Biography information for Steve McCabe

1146686

registered interest
date	26/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken, in light of the European Medicines Agency formally declaring that it recognises Post SSRI Sexual Dysfunction (PSSD) as a medical condition that can outlast discontinuation of SSRI and SNRI antidepressants, to provide symptomatic relief to those suffering from that condition on a long-term basis.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	291225
answer	answer is ministerial correction date of answer 01/10/2019 answer text <p>The European Medicines Agency (EMA) has not formally recognised Post SSRI Sexual Dysfunction (PSSD) as a medical condition, as it is not within the remit of the EMA to classify medical conditions.</p><p>The EMA’s Pharmacovigilance Risk Assessment Committee evaluated the available safety data on the risk of sexual disorders with selective serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors to establish whether the existing information about the possible side effect of sexual dysfunction fully reflected the available evidence. The review did not include an evaluation of whether PSSD is a specific medical condition.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 01/10/2019 15:34:19 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	298 label Biography information for Steve McCabe